Awarded
Ustekinumab 130 mg intravenoso
Original language: Spanish
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- ACCORD HEALTHCARE, S.L.U., AMGEN, S.A., FRESENIUS KABI ESPAÑA, S.A., JANSSEN-CILAG, S.A., KERN PHARMA, S.L., Sandoz Farmaceutica
- Contract value
- €12,296,183
- Bids received
- 16
- Published
- 12 Jun 2026
- Awarded
- 9 Jul 2025
- Contract start
- 9 Jul 2025
- Contract end
- 27 Jul 2026estimated
- Region
- Toledo